Recently, a study with 57 NAFLD patients and 38 healthy people found that the level of LP-PLA2 was greater in patients with fatty liver, and the concentration of LP-PLA2 was strongly associated to histological steatosis scores in patients with NAFLD8. Here, PLA2G7 is linked to metabolic dysfunction-associated steatotic liver disease.